Gradient Investments LLC increased its stake in The Goldman Sachs Group, Inc. (NYSE:GS – Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 70,680 shares of the investment management company’s stock after acquiring an additional 575 shares during the quarter. The Goldman Sachs Group makes up about 1.0% of Gradient Investments LLC’s portfolio, making the stock its 20th biggest holding. Gradient Investments LLC’s holdings in The Goldman Sachs Group were worth $71,484,000 as of its most recent filing with the SEC.
Other large investors also recently added to or reduced their stakes in the company. Optas LLC raised its position in shares of The Goldman Sachs Group by 0.4% in the 4th quarter. Optas LLC now owns 2,553 shares of the investment management company’s stock worth $2,244,000 after buying an additional 11 shares during the period. Pines Wealth Management LLC grew its position in The Goldman Sachs Group by 0.4% during the fourth quarter. Pines Wealth Management LLC now owns 2,566 shares of the investment management company’s stock valued at $2,255,000 after acquiring an additional 11 shares during the period. Welch & Forbes LLC grew its position in The Goldman Sachs Group by 0.8% during the fourth quarter. Welch & Forbes LLC now owns 1,430 shares of the investment management company’s stock valued at $1,257,000 after acquiring an additional 11 shares during the period. First Financial Group Corp increased its stake in The Goldman Sachs Group by 4.7% during the first quarter. First Financial Group Corp now owns 246 shares of the investment management company’s stock worth $208,000 after acquiring an additional 11 shares during the last quarter. Finally, Meadow Creek Wealth Advisors LLC raised its holdings in shares of The Goldman Sachs Group by 1.7% in the 1st quarter. Meadow Creek Wealth Advisors LLC now owns 673 shares of the investment management company’s stock worth $569,000 after purchasing an additional 11 shares during the period. 71.21% of the stock is currently owned by institutional investors and hedge funds.
The Goldman Sachs Group Price Performance
GS stock opened at $1,040.33 on Friday. The company has a debt-to-equity ratio of 3.17, a quick ratio of 0.63 and a current ratio of 0.63. The Goldman Sachs Group, Inc. has a 1 year low of $705.55 and a 1 year high of $1,153.99. The firm has a market cap of $302.91 billion, a P/E ratio of 16.06, a price-to-earnings-growth ratio of 1.05 and a beta of 1.30. The stock has a 50-day simple moving average of $1,056.60 and a 200-day simple moving average of $957.86.
The Goldman Sachs Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 29th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $5.00 per share. This is an increase from The Goldman Sachs Group’s previous quarterly dividend of $4.50. This represents a $20.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 1st. The Goldman Sachs Group’s payout ratio is 27.78%.
More The Goldman Sachs Group News
Here are the key news stories impacting The Goldman Sachs Group this week:
- Positive Sentiment: HSBC upgraded GS to “strong-buy,” improving the stock’s analyst-rating backdrop and potentially attracting additional institutional interest. HSBC upgrades Goldman Sachs
- Positive Sentiment: Goldman Sachs ranked as the leading M&A adviser in South and Central America during the first half of 2026, advising on three transactions valued at a combined $10.4 billion. The activity underscores continued strength in its advisory franchise and could support future fee revenue. Goldman Sachs tops South and Central America M&A rankings
- Positive Sentiment: Goldman Sachs is serving as a joint book-running manager on several recent equity offerings, including Latigo Biotherapeutics’ upsized $345.6 million IPO and Braveheart Bio’s $382.5 million IPO. These mandates generate underwriting fees and highlight healthy demand for new-issue markets. Latigo Biotherapeutics IPO Braveheart Bio IPO
- Neutral Sentiment: Goldman Sachs analysts identified European stocks with substantial potential upside, including Ceres Power. The research may reinforce the firm’s investment-research profile, but its direct impact on GS earnings is limited. Goldman Sachs European stock picks
- Neutral Sentiment: Goldman Sachs BDC reported strong second-quarter investment income and declared dividends. The announcement benefits the Goldman Sachs-branded platform but applies primarily to Goldman Sachs BDC (NYSE: GSBD), not directly to GS. Goldman Sachs BDC second-quarter results
- Negative Sentiment: Criticism of Goldman’s covered-call S&P 500 ETF focuses on fees and the quality of its income generation relative to lower-cost competitors. While the issue concerns an asset-management product rather than GS’s core businesses, it could create pressure on product competitiveness and investor sentiment. Goldman Sachs S&P 500 ETF fee criticism
Wall Street Analyst Weigh In
Several research firms have recently weighed in on GS. Barclays lifted their price objective on The Goldman Sachs Group from $1,048.00 to $1,245.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Keefe, Bruyette & Woods raised their price target on shares of The Goldman Sachs Group from $1,050.00 to $1,130.00 and gave the company a “market perform” rating in a report on Wednesday, July 15th. Oppenheimer cut shares of The Goldman Sachs Group from a “market perform” rating to an “underperform” rating in a research report on Tuesday, June 30th. BNP Paribas Exane decreased their price objective on shares of The Goldman Sachs Group from $970.00 to $940.00 and set a “neutral” rating for the company in a research note on Friday, April 24th. Finally, Wall Street Zen raised shares of The Goldman Sachs Group from a “hold” rating to a “buy” rating in a research report on Saturday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, The Goldman Sachs Group has an average rating of “Moderate Buy” and a consensus target price of $1,062.86.
View Our Latest Analysis on GS
Insider Activity at The Goldman Sachs Group
In other news, CFO Denis P. Coleman sold 6,857 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $973.55, for a total transaction of $6,675,632.35. Following the transaction, the chief financial officer directly owned 31,070 shares of the company’s stock, valued at approximately $30,248,198.50. The trade was a 18.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.55% of the company’s stock.
The Goldman Sachs Group Profile
The Goldman Sachs Group, Inc is a global investment banking and financial services firm headquartered in New York City. Founded in 1869 as a commercial paper business, the company has grown into a diversified financial institution that provides a broad range of services to corporations, financial institutions, governments and individuals. The firm is led by Chief Executive Officer David M. Solomon and operates across major financial centers worldwide.
Goldman Sachs’ core businesses include investment banking, global markets, asset and wealth management, and consumer banking.
See Also
- Five stocks we like better than The Goldman Sachs Group
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding GS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Goldman Sachs Group, Inc. (NYSE:GS – Free Report).
Receive News & Ratings for The Goldman Sachs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Goldman Sachs Group and related companies with MarketBeat.com's FREE daily email newsletter.
